| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ba3b1631b9a9fad66683bfc331af0a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
| filingDate |
2015-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f640e94f98e07dbf76950e2ceb296500
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d46eb8778e92ab3f4ae7ba2791a2b8d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed37f96dd494601af4306cbfe7b84fed |
| publicationDate |
2019-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-3043555-B1 |
| titleOfInvention |
MIRABEGRON FOR THE TREATMENT OF RETINAL DISEASES |
| abstract |
The present invention relates to the use of the anilide of (R) -2- (2-aminothiazol-4 -yl) -4 '- [2 - [(2-hydroxy-2-phenylethyl) amino] ethyl] acetic acid] or a pharmaceutically acceptable analogue, salt or solvate thereof for the treatment of retinal disease. In particular, the invention relates to the use of mirabegron for the treatment of age-related macular degeneration. The invention also relates to a pharmaceutical composition, a medicament and a kit for the treatment of age-related macular degeneration. |
| priorityDate |
2015-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |